hydroxyurea has been researched along with Lung Diseases, Interstitial in 6 studies
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Excerpt | Relevance | Reference |
---|---|---|
"A patient given hydroxyurea for polycythemia suddenly developed severe interstitial pneumonia with fever and hypoxemia." | 7.70 | [Acute interstitial pneumopathy with fever caused by hydroxyurea]. ( Blanc, PL; Hammoud, H; Joasson, JM; Matussière, Y, 2000) |
"A patient given hydroxyurea for polycythemia suddenly developed severe interstitial pneumonia with fever and hypoxemia." | 3.70 | [Acute interstitial pneumopathy with fever caused by hydroxyurea]. ( Blanc, PL; Hammoud, H; Joasson, JM; Matussière, Y, 2000) |
"Hydroxyurea is a cytotoxic agent widely used in the treatment of myeloproliferative disorders." | 1.40 | Hydroxyurea-induced interstitial pneumonitis: case report and review of the literature. ( Angelici, E; Antonaglia, C; Giannelli, V; Internullo, M; Palange, P; Sardo, L; Villani, T, 2014) |
"Hydroxyurea is a drug widely used to control myeloproliferative disorders, due in part to its relative lack of severe side effects." | 1.30 | Hydroxyurea-induced acute interstitial pneumonitis in a patient with essential thrombocythemia. ( Bello, JL; Bendaña, A; Gonzalez, S; Pérez-Encinas, M; Quintás-Cardama, A, 1999) |
"Hydroxyurea is a cytotoxic agent that is being increasingly used for a number of malignant and nonmalignant systemic diseases." | 1.29 | Hydroxyurea-induced acute interstitial lung disease. ( Gadsden, T; Gephardt, G; Kavuru, MS; Lichtin, A, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hilmi, M | 1 |
Bally, C | 1 |
Burns, R | 1 |
Lorillon, G | 1 |
Bergeron, A | 1 |
Fenaux, P | 1 |
Ades, L | 1 |
Internullo, M | 1 |
Giannelli, V | 1 |
Sardo, L | 1 |
Antonaglia, C | 1 |
Villani, T | 1 |
Angelici, E | 1 |
Palange, P | 1 |
Imai, H | 1 |
Matsumura, N | 1 |
Yamazaki, Y | 1 |
Kanayama, Y | 1 |
Masuda, T | 1 |
Kuwako, T | 1 |
Kamide, Y | 1 |
Tomizawa, T | 1 |
Matsumoto, S | 1 |
Mitsui, T | 1 |
Kaira, K | 1 |
Ono, A | 1 |
Koga, Y | 1 |
Shibusawa, N | 1 |
Sunaga, N | 1 |
Hisada, T | 1 |
Yokoo, H | 1 |
Yamada, M | 1 |
Kavuru, MS | 1 |
Gadsden, T | 1 |
Lichtin, A | 1 |
Gephardt, G | 1 |
Quintás-Cardama, A | 1 |
Pérez-Encinas, M | 1 |
Gonzalez, S | 1 |
Bendaña, A | 1 |
Bello, JL | 1 |
Blanc, PL | 1 |
Joasson, JM | 1 |
Hammoud, H | 1 |
Matussière, Y | 1 |
6 other studies available for hydroxyurea and Lung Diseases, Interstitial
Article | Year |
---|---|
Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Combined Modality Therapy; Drug Resistance; Humans; Hy | 2018 |
Hydroxyurea-induced interstitial pneumonitis: case report and review of the literature.
Topics: Aged; Antineoplastic Agents; Female; Humans; Hydroxyurea; Lung Diseases, Interstitial; Respiratory I | 2014 |
Hydroxyurea-induced Pneumonitis in a Patient with Chronic Myelomonocytic Leukemia: An Autopsy Case.
Topics: Aged, 80 and over; Autopsy; Humans; Hydroxyurea; Leukemia, Myelomonocytic, Chronic; Lung Diseases, I | 2015 |
Hydroxyurea-induced acute interstitial lung disease.
Topics: Acute Disease; Aged; Biopsy; Female; Humans; Hydroxyurea; Lung; Lung Diseases, Interstitial; Prednis | 1994 |
Hydroxyurea-induced acute interstitial pneumonitis in a patient with essential thrombocythemia.
Topics: Humans; Hydroxyurea; Lung Diseases, Interstitial; Male; Middle Aged; Radiography, Thoracic; Thromboc | 1999 |
[Acute interstitial pneumopathy with fever caused by hydroxyurea].
Topics: Aged; Aged, 80 and over; Female; Fever; Follow-Up Studies; Humans; Hydroxyurea; Lung Diseases, Inter | 2000 |